AskRx vs Hers
AskRx and Hers both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
AskRx
Best for: coverage in all 50 states, which most sellers will not confirm
Visit AskRx →
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →If you are choosing between AskRx and Hers, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. AskRx leads our six-part score, 8.8 to 6.6. One of the two has an FDA warning letter on record, covered below.
AskRx vs Hers price
AskRx and Hers start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide costs the same at both, $299 a month.
Medications and formats
Both sell semaglutide and tirzepatide.
On format, AskRx prices brand-name pens, while Hers prices compounded injections and brand-name pens.
Where each one treats patients
AskRx lists 50 states, and Hers lists 50 states.
They overlap in 50 states.
Pricing
AskRx
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
What each price covers
Hers' price also covers the medication itself, which AskRx does not claim.
AskRx does not say what its price includes.
Hers is silent on shipping and lab work.
That matters most for the drug: unless AskRx confirms otherwise, budget for medication on top of its listed price.
AskRx
Inclusions not disclosed.
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, AskRx scores 8.8 and Hers 6.6 out of 10.
AskRx is stronger on value (10.0 vs 3.0), trust & safety (7.5 vs 5.5) and support (5.0 vs 3.0).
Effectiveness, user experience and accessibility are within half a point.
AskRx
8.8/10
Hers
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.
AskRx has no FDA warning letter on record with us.
Features & Coverage
| Feature | AskRx | Hers |
|---|---|---|
| Starting Price | $199/mo | $199/mo |
| Features | ✓8 features | 2 features |
| States Available | 50 | 50 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | ✓ Yes | — |
| FDA Warning Letters | ✓None | 1 letter |
About AskRx
The subscription buys a physician, not a drug: $99-149/mo, with medication invoiced separately. AskRx never dispenses, compounds or sells anything; it routes the script to a manufacturer pharmacy, NovoCare or LillyDirect, whichever the patient picks. Its board-certified physicians write nothing compounded, only FDA-approved brand-name GLP-1s: Zepbound (tirzepatide), plus the Wegovy pen and pill (semaglutide). LegitScript approval and HIPAA compliance are claimed across all 50 states, and the subscription may qualify for HSA/FSA.
Read our full AskRx review →About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →Pros & Cons
AskRx
What we like
- Semaglutide costs $199 a month, 80% below the $997 median for brand-name semaglutide across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Serves all 50 states
- We found no FDA warning letters issued to AskRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
AskRx wins this one, 8.8 to 6.6, above all for coverage in all 50 states, which most sellers will not confirm. Hers fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose AskRx if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Embody
Knowing which pharmacy fills the vial: it names RedRock Pharmacy
From $79/mo
Get started →YourEra
Semaglutide at $99/month, 63% below the typical price
From $99/mo
Get started →Gala
Moving between compounded and brand without changing seller
From $149/mo
Get started →AskRx vs Hers: FAQ
Close alternatives to AskRx and Hers
- AskRx vs Hims
- AskRx vs Care Bare Rx
- AskRx vs Concierge MD LA
- Hers vs Hims
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.